SARS-CoV-2 Disables Key Components of Human Cells’ Defense System
SARS-CoV-2 Disables Key Components of Human Cells’ Defense System
Researchers detail how viral proteins interact with host RNA to disrupt the cell’s ability to fight back against infection.
SARS-CoV-2 Disables Key Components of Human Cells’ Defense System
SARS-CoV-2 Disables Key Components of Human Cells’ Defense System

Researchers detail how viral proteins interact with host RNA to disrupt the cell’s ability to fight back against infection.

Researchers detail how viral proteins interact with host RNA to disrupt the cell’s ability to fight back against infection.

SARS-CoV-2
Decoy Cells Trick SARS-CoV-2, Reduce Cytokines In Vitro
Decoy Cells Trick SARS-CoV-2, Reduce Cytokines In Vitro
Max Kozlov | Oct 14, 2020
Genetically engineered cells that overproduce ACE2, the receptor the novel coronavirus uses to enter cells, neutralize infection in vitro and mop up inflammatory cytokines in mice.
US Tops List of COVID-19 and All-Cause Death Rates Since May
US Tops List of COVID-19 and All-Cause Death Rates Since May
Max Kozlov | Oct 14, 2020
The authors of a new analysis conclude that tens of thousands of lives could have been saved with a more coordinated national response to the coronavirus.
Johnson & Johnson Pauses COVID-19 Vaccine Trials
Johnson & Johnson Pauses COVID-19 Vaccine Trials
Amanda Heidt | Oct 13, 2020
The company voluntarily paused its studies, including one in Phase 3, after an unexplained illness in a patient.
Scientists’ Advice for Ways to Ward Off the Coronavirus
Scientists’ Advice for Ways to Ward Off the Coronavirus
Shawna Williams | Oct 9, 2020
We asked experts for measures people can take that may help boost defenses against COVID-19 and other respiratory diseases.
COVID-19 Diagnostics: How Do Saliva Tests Compare to Swabs?
COVID-19 Diagnostics: How Do Saliva Tests Compare to Swabs?
Amanda Heidt | Oct 9, 2020
From hospitals and college campuses to remote villages in French Guiana, scientists have pit the two approaches against one other. See which one comes out ahead.
A Challenge Trial for COVID-19 Would Not Be the First of Its Kind
A Challenge Trial for COVID-19 Would Not Be the First of Its Kind
Jef Akst | Oct 8, 2020
Although scientists debate the ethics of deliberately infecting volunteers with SARS-CoV-2, plenty of consenting participants have been exposed to all sorts of pathogens in prior trials.
Stomach Acid & Heartburn Drugs Linked with COVID-19 Outcomes
Stomach Acid & Heartburn Drugs Linked with COVID-19 Outcomes
Ashley Yeager | Oct 7, 2020
While sick with COVID-19, President Trump is taking an antacid. Doctors have been exploring whether these medicines can treat SARS-CoV-2 infections, and the results are mixed.
What We Know About Donald Trump’s COVID-19 Treatment Plan
What We Know About Donald Trump’s COVID-19 Treatment Plan
Lisa Winter | Oct 5, 2020
The President was hospitalized on Friday evening and has been receiving an aggressive treatment of experimental and standard drugs.
SARS-CoV-2 Antibody Durability
SARS-CoV-2 Antibody Durability
The Scientist Creative Services Team | Oct 2, 2020
Experts will discuss their research on SARS-CoV-2 antibody persistence and immune memory in recovered COVID-19 patients and the implications for protective immunity.